Buy Surya Pharmaceutical Ltd


FREE Portfolio Manager

Buy Surya Pharmaceutical Ltd

Mkt Cap 165.73

P/E 5.23

Last Traded Price: 115.RS

  • Buy Surya Pharmaceutical for 200% -300% in a time span of 1-2 years. Surya Pharma being a Small Cap company chances of risk is high , But Very High returns can be expected.Company’s foray into CRAM space is expected to yield very good returns in near term.
  • Surya Pharmaceutical Limited is a government recognized Export-House with a focus on manufacturers and exporters of bulk semi-synthetic penicillin antibiotics.
  • The company carries its manufacturing through four State-of-the-art manufacturing units, Three for Active Pharmaceutical Ingredients and One for Formulations, with a capacity of around 2000 Metric Tonnes of API’s, 600 million capsules and 600 million tablets per annum with specialization in betalactums, cephalosporins and non-sedative antihistamines.
  • Surya Pharmaceuticals is one amongst the top 5 producers of India in these segments and one among the top 50 Pharmaceutical companies of India. The customer base of the company is spread out to more than 70 countries around the globe with more than 500 customers contributing to annual business of almost US$ 50 million.
  • With special emphasis of Research & Development activities at a dedicated well equipped R&D centre at Panchkula near Chandigarh, steered by highly qualified scientists from the industry, the company assures the qualities of quick time to market, quality optimization & cost effectiveness in product delevery.
  • In a short span of just 13 years, the company continued to maintain an upward, growing and successful track record and has well positioned in domestic as well as international market.

NegativeS:

  • Very Low promoter Holding
  • Appreciating Rupee to reduce Margins
Sun to give up 3 drugs for Taro
Priyagold claims its right,valued
Mahurut Picks - 2007
Buy Glenmark Pharma for Target Rs 728
Get ready to cough up more for medicines
Buy L & T
Must Buy Pyramid Saimira
Buy RIL
Marksans Pharma acquires Relonchem

Enter your email address:

Delivered by FeedBurner

Leave a Reply